These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Allopregnanolone in women with premenstrual syndrome. Bicíková M; Dibbelt L; Hill M; Hampl R; Stárka L Horm Metab Res; 1998 Apr; 30(4):227-30. PubMed ID: 9623639 [TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine response to an intravenous L-tryptophan challenge in women with premenstrual syndrome. Rasgon N; McGuire M; Tanavoli S; Fairbanks L; Rapkin A Fertil Steril; 2000 Jan; 73(1):144-9. PubMed ID: 10632430 [TBL] [Abstract][Full Text] [Related]
5. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Rapkin AJ; Morgan M; Goldman L; Brann DW; Simone D; Mahesh VB Obstet Gynecol; 1997 Nov; 90(5):709-14. PubMed ID: 9351749 [TBL] [Abstract][Full Text] [Related]
6. [Correlation between neurotransmitters and neurosteroids and premenstrual syndrome patients of Gan-yang ascending syndrome and Gan-qi stagnation syndrome]. Gao H; Xia T; Qiao MQ Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Nov; 32(11):1503-7. PubMed ID: 23359974 [TBL] [Abstract][Full Text] [Related]
7. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. Wang M; Seippel L; Purdy RH; Bãckström T J Clin Endocrinol Metab; 1996 Mar; 81(3):1076-82. PubMed ID: 8772579 [TBL] [Abstract][Full Text] [Related]
8. The effect of a low dose of alcohol on allopregnanolone serum concentrations across the menstrual cycle in women with severe premenstrual syndrome and controls. Nyberg S; Andersson A; Zingmark E; Wahlström G; Bäckström T; Sundström-Poromaa I Psychoneuroendocrinology; 2005 Oct; 30(9):892-901. PubMed ID: 15979810 [TBL] [Abstract][Full Text] [Related]
9. Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome. Lombardi I; Luisi S; Quirici B; Monteleone P; Bernardi F; Liut M; Casarosa E; Palumbo M; Petraglia F; Genazzani AR Gynecol Endocrinol; 2004 Feb; 18(2):79-87. PubMed ID: 15195499 [TBL] [Abstract][Full Text] [Related]
10. Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome. Cubeddu A; Bucci F; Giannini A; Russo M; Daino D; Russo N; Merlini S; Pluchino N; Valentino V; Casarosa E; Luisi S; Genazzani AR Psychoneuroendocrinology; 2011 May; 36(4):523-30. PubMed ID: 20933336 [TBL] [Abstract][Full Text] [Related]
11. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome. Eriksson E; Alling C; Andersch B; Andersson K; Berggren U Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413 [TBL] [Abstract][Full Text] [Related]
13. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms. Redei E; Freeman EW Psychoneuroendocrinology; 1995; 20(3):259-67. PubMed ID: 7777654 [TBL] [Abstract][Full Text] [Related]
15. Increased neuroactive steroid concentrations in women with bipolar disorder or major depressive disorder. Hardoy MC; Serra M; Carta MG; Contu P; Pisu MG; Biggio G J Clin Psychopharmacol; 2006 Aug; 26(4):379-84. PubMed ID: 16855455 [TBL] [Abstract][Full Text] [Related]
16. The correlation between neurosteroids and neurotransmitters with liver yang rising and liver qi stagnation types of premenstrual syndrome. Gao H; Shang YZ; Xia T; Qiao MQ; Zhang HY; Ma YX Gynecol Endocrinol; 2014; 30(12):913-7. PubMed ID: 25211539 [TBL] [Abstract][Full Text] [Related]
17. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. Schmidt PJ; Purdy RH; Moore PH; Paul SM; Rubinow DR J Clin Endocrinol Metab; 1994 Nov; 79(5):1256-60. PubMed ID: 7962316 [TBL] [Abstract][Full Text] [Related]
18. Serum leptin levels in patients with premenstrual syndrome treated with GnRH analogues alone and in association with tibolone. Tommaselli GA; Di Carlo C; Bifulco G; Di Spiezio Sardo A; Pellicano M; Nappi C Clin Endocrinol (Oxf); 2003 Dec; 59(6):716-22. PubMed ID: 14974912 [TBL] [Abstract][Full Text] [Related]
19. Women with acute intermittent porphyria have a defect in 5α-steroid production during the menstrual cycle. Innala E; Bäckström T; Poromaa IS; Andersson C; Bixo M Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1445-52. PubMed ID: 22924787 [TBL] [Abstract][Full Text] [Related]
20. Physical symptoms in premenstrual syndrome are related to plasma progesterone and desoxycorticosterone. Seippel L; Eriksson O; Grankvist K; von Shoultz B; Bäckström T Gynecol Endocrinol; 2000 Jun; 14(3):173-81. PubMed ID: 10923278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]